entrectinib 100 MG Oral Capsule [Rozlytrek]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

entrectinib 100 MG Oral Capsule [Rozlytrek]

100 MG · Oral Capsule · oral

A form of entrectinib →

entrectinib 100 MG Oral Capsule [Rozlytrek] — Other protein kinase inhibitors. Strength, form, class, interactions & more.

entrectinib 100 MG Oral Capsule [Rozlytrek]

Active ingredient

Classification

Other protein kinase inhibitors

Drug interactions

Entrectinib has several drug interactions that require caution or avoidance during coadministration.

  • majormoderate or strong CYP3A inhibitors — increases entrectinib plasma concentrations, which could increase the frequency or severity of adverse reactions
  • majorgrapefruit products — inhibits CYP3A, potentially increasing entrectinib plasma concentrations
  • majormoderate or strong CYP3A inducers — decreases entrectinib plasma concentrations, which may reduce ROZLYTREK efficacy
  • majorother products that prolong QT/QTc interval — QTc interval prolongation can occur

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.